These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 16253591

  • 1. Neurological complications following percutaneous coronary interventions (a report from the 2000-2001 New York State Angioplasty Registry).
    Wong SC, Minutello R, Hong MK.
    Am J Cardiol; 2005 Nov 01; 96(9):1248-50. PubMed ID: 16253591
    [Abstract] [Full Text] [Related]

  • 2. Outcomes following immediate (ad hoc) versus staged percutaneous coronary interventions (report from the 2000 to 2001 New York State Angioplasty Registry).
    Feldman DN, Minutello RM, Gade CL, Wong SC.
    Am J Cardiol; 2007 Feb 15; 99(4):446-9. PubMed ID: 17293181
    [Abstract] [Full Text] [Related]

  • 3. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry).
    Feldman DN, Gade CL, Slotwiner AJ, Parikh M, Bergman G, Wong SC, Minutello RM, New York State Angioplasty Registry.
    Am J Cardiol; 2006 Nov 15; 98(10):1334-9. PubMed ID: 17134624
    [Abstract] [Full Text] [Related]

  • 4. Incidence and predictors of stroke associated with percutaneous coronary intervention.
    Aggarwal A, Dai D, Rumsfeld JS, Klein LW, Roe MT, American College of Cardiology National Cardiovascular Data Registry.
    Am J Cardiol; 2009 Aug 01; 104(3):349-53. PubMed ID: 19616666
    [Abstract] [Full Text] [Related]

  • 5. Characteristics of cerebrovascular accidents after percutaneous coronary interventions.
    Dukkipati S, O'Neill WW, Harjai KJ, Sanders WP, Deo D, Boura JA, Bartholomew BA, Yerkey MW, Sadeghi HM, Kahn JK.
    J Am Coll Cardiol; 2004 Apr 07; 43(7):1161-7. PubMed ID: 15063423
    [Abstract] [Full Text] [Related]

  • 6. Impact of the New York State Cardiac Surgery and Percutaneous Coronary Intervention Reporting System on the management of patients with acute myocardial infarction complicated by cardiogenic shock.
    Apolito RA, Greenberg MA, Menegus MA, Lowe AM, Sleeper LA, Goldberger MH, Remick J, Radford MJ, Hochman JS.
    Am Heart J; 2008 Feb 07; 155(2):267-73. PubMed ID: 18215596
    [Abstract] [Full Text] [Related]

  • 7. Predicting vascular complications in percutaneous coronary interventions.
    Piper WD, Malenka DJ, Ryan TJ, Shubrooks SJ, O'Connor GT, Robb JF, Farrell KL, Corliss MS, Hearne MJ, Kellett MA, Watkins MW, Bradley WA, Hettleman BD, Silver TM, McGrath PD, O'Mears JR, Wennberg DE, Northern New England Cardiovascular Disease Study Group.
    Am Heart J; 2003 Jun 07; 145(6):1022-9. PubMed ID: 12796758
    [Abstract] [Full Text] [Related]

  • 8. Major bleeding complicating contemporary primary percutaneous coronary interventions-incidence, predictors, and prognostic implications.
    Fuchs S, Kornowski R, Teplitsky I, Brosh D, Lev E, Vaknin-Assa H, Ben-Dor I, Iakobishvili Z, Rechavia E, Battler A, Assali A.
    Cardiovasc Revasc Med; 2009 Jun 07; 10(2):88-93. PubMed ID: 19327670
    [Abstract] [Full Text] [Related]

  • 9. Persistent sex difference in hospital outcome following percutaneous coronary intervention: results from the New York State reporting system.
    Srinivas VS, Garg S, Negassa A, Bang JY, Monrad ES.
    J Invasive Cardiol; 2007 Jun 07; 19(6):265-8. PubMed ID: 17541128
    [Abstract] [Full Text] [Related]

  • 10. The impact of ejection fraction on outcomes after percutaneous coronary intervention in patients with congestive heart failure: an analysis of the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry and Dynamic Registry.
    Holper EM, Blair J, Selzer F, Detre KM, Jacobs AK, Williams DO, Vlachos H, Wilensky RL, Coady P, Faxon DP, Percutaneous Transluminal Coronary Angioplasty Registry and Dynamic Registry Investigators.
    Am Heart J; 2006 Jan 07; 151(1):69-75. PubMed ID: 16368294
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of glycoprotein IIb/IIIa inhibitor use during primary coronary angioplasty: results of propensity analysis using the New York State Percutaneous Coronary Intervention Reporting System.
    Srinivas VS, Skeif B, Negassa A, Bang JY, Shaqra H, Monrad ES.
    Am J Cardiol; 2007 Feb 15; 99(4):482-5. PubMed ID: 17293189
    [Abstract] [Full Text] [Related]

  • 12. [Percutaneous coronary interventions in elderly patients: clinical indications and adjunctive medical treatment. The Italian Drug Evaluation in Angioplasty (IDEA) study].
    Bossi I, Piccaluga E, Scatturin M, Corvaja N, Pasquetto G, Steffanon L, Oberhollenzer R, Colombo P, Bolognese L, Savonitto S.
    G Ital Cardiol (Rome); 2006 Feb 15; 7(2):136-44. PubMed ID: 16532725
    [Abstract] [Full Text] [Related]

  • 13. The impact of advanced chronic kidney disease on in-hospital mortality following percutaneous coronary intervention for acute myocardial infarction.
    Vasu S, Gruberg L, Brown DL.
    Catheter Cardiovasc Interv; 2007 Nov 01; 70(5):701-5. PubMed ID: 17932900
    [Abstract] [Full Text] [Related]

  • 14. Early sustained ventricular arrhythmias complicating acute myocardial infarction.
    Piccini JP, Berger JS, Brown DL.
    Am J Med; 2008 Sep 01; 121(9):797-804. PubMed ID: 18724970
    [Abstract] [Full Text] [Related]

  • 15. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
    Brieger D, Van de Werf F, Avezum A, Montalescot G, Kennelly BM, Granger CB, Goodman SG, Dabbous OH, Agnelli G, GRACE Investigators.
    Am Heart J; 2007 Jun 01; 153(6):960-9. PubMed ID: 17540196
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).
    Bromberg-Marin G, Marin-Neto JA, Parsons LS, Canto JG, Rogers WJ, National Registry of Myocardial Infarction-4.
    Am J Cardiol; 2006 Nov 01; 98(9):1125-31. PubMed ID: 17056312
    [Abstract] [Full Text] [Related]

  • 17. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era.
    Hannan EL, Racz M, Holmes DR, King SB, Walford G, Ambrose JA, Sharma S, Katz S, Clark LT, Jones RH.
    Circulation; 2006 May 23; 113(20):2406-12. PubMed ID: 16702469
    [Abstract] [Full Text] [Related]

  • 18. Decreased complication rates using the transradial compared to the transfemoral approach in percutaneous coronary intervention in the era of routine stenting and glycoprotein platelet IIb/IIIa inhibitor use: a large single-center experience.
    Eichhöfer J, Horlick E, Ivanov J, Seidelin PH, Ross JR, Ing D, Daly P, Mackie K, Ridley B, Schwartz L, Barolet A, Dzavík V.
    Am Heart J; 2008 Nov 23; 156(5):864-70. PubMed ID: 19061699
    [Abstract] [Full Text] [Related]

  • 19. Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention.
    Mishra S, Chu WW, Torguson R, Wolfram R, Deible R, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R.
    Am J Cardiol; 2006 Sep 01; 98(5):608-12. PubMed ID: 16923445
    [Abstract] [Full Text] [Related]

  • 20. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
    O'Donoghue M, Antman EM, Braunwald E, Murphy SA, Steg PG, Finkelstein A, Penny WF, Fridrich V, McCabe CH, Sabatine MS, Wiviott SD.
    J Am Coll Cardiol; 2009 Aug 18; 54(8):678-85. PubMed ID: 19679245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.